Companies: 10,795·Total market cap: $144.5T
Envoy Medical, Inc.

Envoy Medical, Inc.

COCHNASDAQHealthcare● Active
$0.66
$-0.00(-0.33%)
Market Cap$13707200
P/E Ratio—
52W High$1.89
52W Low$0.363
PE RatioMarket CapForecast

Envoy Medical, Inc. (COCH) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

coch · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Envoy Medical, Inc. (COCH) measures how much investors pay for each dollar of the company's trailing earnings. COCH's current PE ratio of N/A is calculated by dividing its stock price of $0.66 by its TTM earnings per share of -$0.34.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.30
Based on 1 analyst
EPS (TTM)
-$0.34
TTM · diluted EPS
PEG Ratio
-0.09
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Envoy Medical, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Envoy Medical, Inc.
Envoy Medical, Inc.You
COCH
$14MN/A—-$0.34
Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc.
ADGM
$11MN/A—-$1.51
Aditxt, Inc.
Aditxt, Inc.
ADTX
$0MN/A—-$1116.70
Allurion Technologies Inc.
Allurion Technologies Inc.
ALUR
$6MN/A—-$0.38
Athira Pharma, Inc.
Athira Pharma, Inc.
ATHA
$27MN/A—-$24.70
Co-Diagnostics, Inc.
Co-Diagnostics, Inc.
CODX
$6MN/A—-$35.25
Healthcare Triangle, Inc.
Healthcare Triangle, Inc.
HCTI
$3MN/A—-$15308.56

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
—$-1.21—
2024-12-31
FY2024
—$-1.11—
2023-12-31
FY2023
—$-2.38—
2022-12-31
FY2022
—$-1.57—
2021-12-31
FY2021
—$-0.85—
2020-12-31
FY2020
—$-0.00—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Envoy Medical, Inc. (COCH) measures how much investors pay for each dollar of the company's trailing earnings. COCH's current PE ratio of N/A is calculated by dividing its stock price of $0.66 by its TTM earnings per share of -$0.34.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.66 ÷ -$0.34 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

COCH pe ratio · 6 questions

COCH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.66 and TTM EPS of -$0.34. Data sourced from Financial Modeling Prep via COCH's SEC 10-K and 10-Q filings.

COCH PE ratioWhat is COCH PE ratioCurrent PE ratio of COCHCOCH PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Envoy Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09